Press Releases
Headline news alert - receive headline stories by email every time a press release is issued
|
ImaRx Therapeutics and Microbix Biosystems Terminate Letter of Intent for Sale of Urokinase |
|
|
CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger |
|
|
CryoCor Reports Going Concern Statement and Receives Notification From Nasdaq Relating to Minimum Stockholders' Equity |
|
|
CryoCor Reports 2007 Results |
|
|
CryoCor Announces Web cast and Conference Call of 2007 Year End Results |
|
|
CryoCor Atrial Fibrillation Study Published in the Journal of the American College of Cardiology |
|
|
CryoCor Requests International Trade Commission Investigation Into CryoCath for Patent Infringement |
|
|
CryoCor to Present at Roth Capital Partners 20th Annual OC Growth Stock Conference |
|
|
United States Patent Office Grants CryoCor's Request for Patent Interference |
|
|
Dr. Warren Jackman Joins CryoCor Scientific Advisory Board |
|
|
CryoCor Files Patent Infringement Lawsuits Against CryoCath |
|
|
CryoCor to Highlight Products at 13th Annual International Boston Atrial Fibrillation Symposium |
|
|
CryoCor Reports Publication in Circulation for Treatment of Atrial Fibrillation |
|
|
Chem Rx Reaches Key Expansion Milestones |
|
|
Raptor Pharmaceuticals Acquires Orphan Clinical Program |
|
|
CryoCor Files Response to Patent Infringement Lawsuit |
|
|
CryoCor to Present at Lazard Capital Markets Fourth Annual Healthcare Conference |
|
|
CryoCor Reports Third Quarter 2007 Results and Provides Commercial and Clinical Update |
|
|
CryoCor Announces Web cast and Conference Call of Third Quarter 2007 Results |
|
|
CryoCor Appoints New Vice President of Sales and Marketing |
|
|
CryoCor to Present at CIBC World Markets 18th Annual Healthcare Conference |
|
|
CryoCor Responds to Patent Infringement Lawsuit |
|
|
CryoCor to Present at Maxim Group First Annual Growth Conference in New York |
|
|
CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation |
|
|
CryoCor to Present at Roth Capital Partners 5th Annual New York Conference |
|
|
CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation |
|
|
CryoCor Reports Second Quarter 2007 Results and Provides Clinical Update |
|
|
CryoCor Receives FDA Approval for Right Atrial Flutter |
|
|
CryoCor Announces Web Cast and Conference Call of Second Quarter 2007 Results |
|
|
Boston Scientific and CryoCor Announce Strategic Collaboration in Atrial Fibrillation |
|
|
FDA Advisory Panel Recommends Approval of CryoCor's PMA |
|
|
CryoCor Completes New Credit Facility |
|
|
CryoCor Confirms FDA Advisory Panel Meeting |
|
|
New South Wales Australia Approves Ticket-In Ticket-Out (TITO) |
|
|
CryoCor Reports First Quarter 2007 Results and Provides Clinical Update |
|
|
CryoCor Announces Web cast and Conference Call of First Quarter 2007 Results |
|
|
CryoCor Raises $5.45 Million in Private Placement |
|
|
CryoCor Reports Going Concern Statement |
|
|
VeriChip Corporation to Present at Maryland Patient Safety Conference on March 23, 2007 |
|
|
CryoCor Provides PMA Update |
|
|
CryoCor PMA to be Reviewed at FDA Panel |
|
|
CryoCor Reports 2006 Results and Provides Clinical Update |
|
|
CryoCor Announces Web cast and Conference Call of Year End Results and Clinical Update |
|
|
CryoCor Announces Additions to Scientific Advisory Board |
|
|
CryoCor Amends PMA for Atrial Flutter |
|
|
CryoCor Reports Third Quarter 2006 Results and Provides Clinical Update |
|
|
CryoCor Announces Web cast and Conference Call of Third Quarter 2006 Results |
|
|
CryoCor PMA Amendment Delayed Until November |
|
|
CryoCor to Present at Roth Capital Partners New York Conference |
|
|
CryoCor Announces New Chief Medical Officer |
|
|
CryoCor Receives Nasdaq Letter |
|
|
CryoCor Reports Second Quarter 2006 Results and Provides Clinical Update |
|
|
CryoCor Announces Addition to Board of Directors |
|
|
CryoCor Announces Web Cast and Conference Call of Second Quarter 2006 Results |
|
|
CryoCor Reports First Quarter 2006 Results and Provides Clinical Update |
|
|
CryoCor Announces Web Cast and Conference Call of First Quarter 2006 Results |
|
|
CryoCor Announces Changes at Executive Level |
|
|
CryoCor to Present at The Wall Street Analyst Forum Analyst Conference |
|
|
CryoCor Reports Fourth Quarter 2005 Results and Provides Guidance for 2006 |
|
|
CryoCor Provides Information on Restructuring Plans |
|
|
CryoCor Announces Web cast and Conference Call of Fourth Quarter 2005 Results |
|
|
CryoCor to Present at Roth Capital Partners 18th Annual Growth Stock Conference |
|
|
CryoCor Receives Communication From FDA |
|
|
CryoCor Updates FDA Review of Atrial Flutter PMA |
|
|
CryoCor to Present at First Albany Capital Growth Conference |
|
|
Abstract on CryoCor's Cardiac Cryoablation System Presented at American Heart Association |
|
|
CryoCor Provides Regulatory Update and Reports Third Quarter 2005 Results |
|
|
CryoCor Announces Web cast and Conference Call of Third Quarter 2005 Results |
|
|
CryoCor to Present at Roth Capital Partners New York Conference |
|
|
CryoCor Reports Second Quarter Results |
|
|
CryoCor Reports Progress in FDA Review of Atrial Flutter PMA |
|
|
CryoCor Announces Web Cast and Conference Call of Second Quarter 2005 Results |
|
|
CryoCor, Inc. Submits PMA for Atrial Flutter |
|
|
CryoCor, Inc. Announces Pricing of Initial Public Offering |
|
|
CryoCor Appoints Dr. Edward Brennan, Chief Operating Officer |
|
|
Senator Bill Bradley Addresses CryoCor Atrial Fibrillation Clinical Trial Investigators |
|
|
CryoCor Announces its Cardiac Cryoablation Catheters, Approved for use in U.S. Pivotal Trials and CE Marked in Europe |
|
|
CryoCor Receives FDA Clearance for Breva(TM) Surgical Probe for the Treatment of Cardiac Arrhythmias |
|
|
Over 90% Acute Success Achieved in Treating Atrial Fibrillation, the Most Frequently Occurring Cardiac Arrhythmia, With CryoCor's Cryoablation System |
|
|
CryoCor Appoints VP Human Resources and Names New VP Finance and Chief Financial Officer |
|
|
CryoCor Receives FDA Approval to Begin Clinical Study for Atrial Fibrillation |
|
|
CryoCor Begins U.S. Pivotal Clinical Trial for Atrial Flutter |
|
|
CryoCor Progresses in Clinical Studies and Strengthens Clinical Team |
|
|
CryoCor Raises $27.5 Million to Accelerate U.S. Clinical Development and Product Development Programs |
|
|
CryoCor Presents Promising Clinical Results at ACC |
|
|
CryoCor Clinical Progress Update |
|
|
First 4 Patients Successfully Treated for Atrial Flutter Using CryoCor's Cryoablation System |
|
|
CryoCor Announces Treatment of First Patient in the U.S. and Positive International Clinical Trial Results |
|
|
CryoCor Begins Clinical Trial for Irregular Heartbeats |
|
|
CryoCor Appoints New Vice President of Research and Development |
|
|
CryoCor Raises $12.0 Million to Accelerate Clinical Development |
|
|
CryoCor Completes CE Mark Clinical Trial Enrollment for Irregular Heartbeats |
|
|
CryoCor Expands Clinical Trial Sites for Cardiac Arrhythmias; Third Site to Treat Irregular Heartbeats Opened in The Netherlands |
|
|
CryoCor Clinical Trial for Cardiac Arrhythmias Initiated on Two Continents |
|
|
CryoCor, Inc. Opens Office for Clinical Trials in Europe, Expands Worldwide Headquarters and Strengthens Management Team |
News Headlines from:
